Liver disease, carbohydrate metabolism and diabetes (Q35535202)

8 August 2017

1 reference

title

Liver disease, carbohydrate metabolism and diabetes (English)

1 reference

8 August 2017

1 reference

Shmueli E

1 reference

8 August 2017

Record CO

series ordinal

1 reference

8 August 2017

Alberti KG

series ordinal

1 reference

8 August 2017

publication date

1 October 1992

1 reference

Bailliere's clinical endocrinology and metabolism

8 August 2017

published in

1 reference

8 August 2017

1 reference

8 August 2017

1 reference

8 August 2017

page(s)

719-743

1 reference

Influence of growth hormone on splanchnic glucose production in man

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Regulation of glycogen synthesis from glucose and gluconeogenic precursors by insulin in periportal and perivenous rat hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Lactate and glucose exchange across the forearm, legs, and splanchnic bed during and after prolonged leg exercise

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Splanchnic and peripheral glucose and lactate metabolism during and after prolonged arm exercise

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Metabolic Changes in Active Chronic Hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Glucagon metabolism in normal subjects and in cirrhotic patients before and after portasystemic venous shunt surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Paradoxical elevation of growth hormone in active chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Inhibitory effect of insulin on gluconeogenesis by isolated rat hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

The effect of growth hormone on glucose metabolism and insulin secretion in man

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Hepatic disposal of biosynthetic human insulin and porcine C-peptide in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

The measurement of metabolite exchange across muscle beds

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Metabolic clearance of human growth hormone in patients with hepatic and renal failure, and in the isolated perfused pig liver

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Hormonal and metabolic changes during exercise in cirrhotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Mechanism of insulin resistance in human liver cirrhosis. Evidence of a combined receptor and postreceptor defect

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Feedback inhibition of insulin secretion is altered in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Insulin resistance in human liver cirrhosis is not modified by porto-systemic surgical shunt.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

The effect of intravenous L-tryptophan on prolactin and growth hormone and mood in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Zonation of glycogen and glucose syntheses, but not glycolysis, in rat liver

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

The Effect of Somatostatin on Glucose Uptake and Production by Rat Tissues in Vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Glucose intolerance and insulin resistance in patients with liver disease. II. A study of etiologic factors and evaluation of insulin actions

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Interaction between Norepinephrine and Serotonin in the Neuroendocrine Control of Growth Hormone Release in the Rat*

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Use of the splanchnic/hepatic balance technique in the study of glucose metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Regulation of hepatic glucose metabolism in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Effects of treadmill exercise on fuel metabolism in hepatic cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Hyperglucagonemia and insulin-mediated glucose metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Effect of acute inhibition of lipolysis on operation of the glucose-fatty acid cycle in hepatic cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Glucose Homeostasis in Viral Hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Acute Metabolic Effects of Human Growth Hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Insulin-like growth factors and insulin: comparative aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Erythrocyte insulin receptors in patients with chronic liver diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Role of insulin resistance in the pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Nutrition and somatomedin: nutritionally regulated release of somatomedins and somatomedin inhibitors from perfused livers in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Insulin and glucagon concentrations in portal and peripheral veins in patients with hepatic cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Glucose, Insulin and Somatostatin Infusion for the Determination of Insulin Resistance in Liver Cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Insulin resistance in liver cirrhosis: decreased insulin binding to circulating monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Somatostatin infusion in liver cirrhosis: glucagon control of glucose homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Short-term metabolic effects of recombinant human insulin-like growth factor I in healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Insulin action and cirrhosis: insulin binding and lipogenesis in isolated adipocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

The effect of portacaval anastomosis on oral carbohydrate tolerance and on plasma insulin levels

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Hypogonadism in liver cirrhosis: implication in altered amino acid metabolism in muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Impact of glucose ingestion on hepatic and peripheral glucose metabolism in man: an analysis based on simultaneous use of the forearm and double isotope techniques

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Hyperinsulinism of hepatic cirrhosis: Diminished degradation or hypersecretion?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

C-peptide and Insulin in Liver Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Functional specialization of different hepatocyte populations

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Insulin resistance, insulin insensitivity, and insulin unresponsiveness: a necessary distinction

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

The glucose paradox. Is glucose a substrate for liver metabolism?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Glycogen synthesis by rat hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Evidence for an Augmented Glucagon Dependence of Hepatic Glucose Production in Cirrhosis of the Liver*

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Somatostatin reduces posthypoglycemic insulin resistance in insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

The relationship between insulin sensitivity and skeletal muscle enzyme activities in hepatic cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Relationship between insulin sensitivity, insulin secretion and glucose tolerance in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Time course and significance of changes in hepatic fructose-2,6-bisphosphate levels during refeeding of fasted rats

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Forearm glucose uptake in cirrhosis and its relationship to glucose tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Physiological concentrations of growth hormone exert insulin-like and insulin antagonistic effects on both hepatic and extrahepatic tissues in man

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Intraportal hyperinsulinemia decreases insulin-stimulated glucose uptake in the dog.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Chronic hyperinsulinemia decreases insulin action but not insulin sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Impaired early insulin response to intravenous glucose in alcoholic liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Insulin and glucagon levels in liver cirrhosis. Relationship with plasma amino acid imbalance of chronic hepatic encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Pancreatic beta-cell function in cirrhotic patients with and without overt diabetes. C-peptide response to glucagon and to meal

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Glucose disposal, beta-cell secretion, and hepatic insulin extraction in cirrhosis: a minimal model assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Elevated plasma glucagon levels in cirrhosis of the liver.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Glucose tolerance and diabetes in chronic liver disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Resistance to insulin suppression of plasma free fatty acids in liver cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Basal energy production rate and substrate use in stable cirrhotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Anabolic regulation of gluconeogenesis by insulin in isolated rat hepatocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Effects of growth hormone on insulin sensitivity and forearm metabolism in normal man

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Skeletal muscle and whole-body protein turnover in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Leucine metabolism in stable cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Pancreatic endocrine function in cirrhotic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Carbohydrate and lipid metabolism in cirrhosis. Evidence that hepatic uptake of gluconeogenic precursors and of free fatty acids depends on effective hepatic flow

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Insulin uptake by the human alcoholic cirrhotic liver

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Effects of intra- and extrahepatic portal systemic shunts on insulin metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Hepatic, gut, and renal substrate flux rates in patients with hepatic cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Nature and quantity of fuels consumed in patients with alcoholic cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Studies on the Metabolic Clearance Rate, Apparent Distribution Space and Plasma Half-Disappearance Time of Unlabelled Human Growth Hormone in Normal Subjects and in Patients with Liver Disease, Renal Disease, Thyroid Disease and Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Plasma insulin, C-peptide, and blood glucose in portal, hepatic and peripheral veins in liver cirrhosis. Effect of intravenous tolbutamide.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Glucose and insulin metabolism in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Insulin binding to erythrocytes in hyperinsulinemic patients with precirrhotic hemochromatosis and cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Insulin resistance in noncirrhotic idiopathic portal hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Effect of physiologic hyperinsulinemia on glucose and lipid metabolism in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Effect of insulin and plasma amino acid concentration on leucine metabolism in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Fructose-2,6-Bisphosphate in Control of Hepatic Gluconeogenesis: From Metabolites to Molecular Genetics

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Disappearance Rates of Plasma Growth Hormone After Intravenous Somatostatin in Renal and Liver Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Glucose turnover in compensated hepatic cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

The mechanism of the carbohydrate intolerance of cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Insulin resistance in cirrhosis: evidence for a post-receptor defect.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Hyperinsulinaemia and insulin resistance of cirrhosis: the importance of insulin hypersecretion

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Glucose intolerance in liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Impaired glucose tolerance and growth hormone in chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Glucose and fat metabolism during short-term starvation in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Differential Effects of Insulin on Splanchnic and Peripheral Glucose Disposal after an Intravenous Glucose Load in Man

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Somatomedin production in normal adults and cirrhotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

The acute metabolic effects of glucagon and its interactions with insulin in forearm tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Elevated growth hormone levels and insulin resistance in patients with cirrhosis of the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Growth hormone and carbohydrate intolerance in cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Hyperglucagonemia in Laennec's cirrhosis. The role of portal-systemic shunting

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Hyperglucagonism and glucagon resistance in cirrhosis. Paradoxical effect of propranolol on plasma glucagon levels.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Glucose intolerance and hyperinsulinemia of cirrhosis are not results of spontaneous or surgical portosystemic shunting.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Hormone and metabolite profiles in alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Serum somatomedin peptides measured by somatomedin A radioreceptor assay in chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Hepatic Clearance of Human Growth Hormone1

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Insulin action in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Down-Regulation of Insulin Receptors in Postnecrotic Cirrhosis of Liver*

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Effect of long chain triglyceride infusion on glucose metabolism in man

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

The euglycemic clamp technique in patients with liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Splanchnic and peripheral glucose and amino acid metabolism in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

A study of carbohydrate metabolism in postnecrotic cirrhosis liver

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Acute and chronic effects of hyperglycaemia on glucose metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

Myofibrillar protein catabolic rates in cirrhotic patients with and without muscle wasting

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980163-6

7 January 2021

10.1016/S0950-351X(05)80163-6

Identifiers

DOI

1 reference

8 August 2017

1 reference